°Q½×°Ï>ªYÄ£¥ÍÂå
¥«³õ­º¨£·sÃÄ ±ÂÅv½Í¤¤
·|­û:hung1201 10149413 µoªí®É¶¡:2020/6/24 ¤U¤È 02:11:23
¥«³õ­º¨£·sÃÄ(¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸) Àø®Ä¤ÀªR p=0.009

6634 ªYÄ£

ªÑ¥»: 3.832»õ

¥D­n·~°È:

¨xŦ¯e¯fªvÀø¤Î¯kµhªvÀø¬ÛÃöÃĪ«¬ã¨s¤Î¶}µo

¸³ºÊ«ùªÑ¤ñ¨Ò: 21.7%(¼W¥[¤¤)

¥~¸ê«ùªÑ¤ñ¨Ò: 0.22%(¼W¥[¤¤)

Ä~Äò©¹¤U¬Ý...!

=============================================================================

²£«~01¡GSNP-610 (ªvÀø¯×ªÕ¨x¯e¯f·sÃÄ)

¾AÀ³¯g: «D°sºë©Ê¯×ªÕ¨xª¢

²£«~Àu¶Õ:

1.¥Ø«e©|µL¼Ð·ÇªvÀøÃĪ«

2.¥«³õ­º¨£·sÃÄ(First-in-class)

3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x

4.µL¦w¥þ©Ê°ÝÃD

¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C

Ävª§¤O:

1.¦h­«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢

2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A­°§C¨x¯×

3.¥i´£¥X¨uÃĥӽСAÀ³¥Î©óªvÀø§³®W«æ©Ê¯×ªÕ¨x

¬ãµo¶¥¬q:

1.¤w³q¹LUSFDA¤ÎTFDA¼f¬d¶i¤JÁ{§É¤G´Á

2.Á{§ÉÀø®Ä¤Î·sªvÀø¾÷ÂàÅçÃÒ

Àø®Ä¤ÀªR¡G

1.²Ä¤@´ÁÁ{§É¸ÕÅç¡Gµ²ªGÅã¥Ü¤HÅé¨Ï¥Î¦w¥þ¡A©Ê½è¨}¦n

2.²Ä¤G´ÁÁ{§É¸ÕÅç¨ä¤¤¤ÀªR¡G17¦ìNASH ¯f¤H (p=0.009)

=============================================================================

²£«~02¡GSNP-630

¾AÀ³¯g:«D°sºë©Ê¯×ªÕ¨xª¢

²£«~Àu¶Õ:

1.¬°Àu¤Æ(Optimized)¤§·s¤Æ¾Ç¹êÅé(NCE)

2.¥«³õ­º¨£·sÃÄ(First-in-class)

3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x

4.§@¬°²Ä¤@¥N²£«~¤W¥««áªº±µÄò¦û¦³¥«³õ¤§²£«~

¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C

Ävª§¤O:

1.¦h­«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢

2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A­°§C¨x¯×

3.Àu¤ÆªºÀø®Ä±j«×¡B§@¥Î®É¶¡

4.µL¦w¥þ©Ê°ÝÃD

¬ãµo¶¥¬q:

1.Á{§É«e

2.¹w©w¥Ó½Ð¬ü°êFDAIND¡B§Ö³t³q¹D(fasttrack)¡C

3.¥Ó½Ð¬ü°ê¬ð¯}©ÊªvÀø(breakthrough therapy)ªº»{©w¡C

Àø®Ä¤ÀªR¡G

1. ¥Ø«e¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.05

=============================================================================

²£«~03¡GSNP-810 (µL¨x¬r©Ê¤îµh·sÃÄ¡B¸Ñ¬r¾¯)

¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃÄ (¸Ñ¼öÂíµh¾¯)

²£«~Àu¶Õ:

1.¦w¥þ¤Æ¦Xª«·s²Õ¦X¡BµL¨x¬r©Ê

2.¸Ñ¨M­¢¤ÁÂåÀø»Ý¨D (Important urgent unmet medical needs)

3.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥i­×§ï©Î§R°£FDA¨x¬rĵ»y¥i¼W¥[¾¯¶q

¥«³õ: ¤AñQÓi×ô¶È¦b¬ü°ê¤@¦~´N¦³40»õ¬ü¤¸ªº¥«³õ

Ävª§¤O:

1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ«

2.¥i§ð¦û¼s¤j¥«³õ¡]NSAID, COX-2 §í¨î¾¯¡BOpioidsÃþ¤îµhÃÄ¥«³õ¡^

3.¥i¬Ù°£¶D³^¶O¡B±Ð¨|°V½m¶O

¬ãµo¶¥¬q:

1.¤w§¹¦¨§C¾¯¶q¡B°ª¾¯¶qÁ{§É¸ÕÅç

2.¤w¥Ó½ÐUSFDA¼Ï&#32445;Á{§É¸ÕÅç¡B±N¥Ó½Ð¬ð¯}©Ê¼f¬d/§Ö³t³q¹D

3.µL¨x¬r©Ê¤AñQÓi×ô¸Ñ¬r¾¯¦¨¤À¡A¤w¥Ó½Ð¬dÅçµn°O¥Î¤§Á{§É¸ÕÅç

=============================================================================

²£«~04¡GSNP-830/ SNP-840

¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃĽƤè(ªvÀø¤¤¡B­««×¯kµh)

²£«~Àu¶Õ:

1.µL¨x¬r©Ê¤AñQÓi×ôªº½Æ¤è

2.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥i­×§ï©Î§R°£FDA¨x¬rĵ»y¡A¥i¼W¥[¾¯¶q

¥«³õ: ¤AñQÓi×ô³B¤èÃĦb¬ü°ê¤@¦~´N¦³27»õ¬ü¤¸ªº¥«³õ

Ävª§¤O:

1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ«½Æ¤è

2.½Æ¤è¤w¥Ñ¬ü°êFDA­n¨D­°¾¯¶q§C©ó325²@§J¡A±N¼vÅTÀø®Ä

3.¦³¨Ï¥Î±M§Q¡A¥i­×§ï©Î§R°£FDA¨x¬rĵ»y

4.¥i¼W¥[¤AñQÓi×ô¾¯¶q

¡]¥Ñ325mg ¦^´_¦Ü500 mg¬Æ¦Ü§ó°ª¡A·|¸û¦³®Ä¡^¥H¼W¥[Àø®Ä¡A©Î´î¤ÖOpioids¾¯¶q¡A­°§C¦¨Å}°Æ§@¥Î

5.¤GªÌ¾Ü¤@±ÂÅv

6.¥i¼W¥[¥«¦û²v

¬ãµo¶¥¬q:

1.SNP-810¨ú±oÃÄÃÒ«á¡A¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê¸ÕÅç

SNP-830 ¤£¬O ·s¦¨¤À ªº·sÃÄ¡A©Ò¥H¤£»Ý­n¶i¦æ²Ä¤@¡A¤G¤Î¤T´ÁÁ{§É´úÅç

µ¥ SNP-810 ®³¨ìÃÄÃÒ«á¡A¥H ·sÀø®Ä½Æ¤è¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê´úÅç ´N¥i¥HÀò±oÃÄÃÒ

=============================================================================

*****************************************************************************

SNP-8 ¨t¦C Àø®Ä¤ÀªR¡G

1. ¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005

1. ¤w¸g§¹¦¨¤§¤HÅé¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005

=============================================================================

*****************************************************************************

¥¼¨Ó¥Ø¼Ð±ÂÅv¥D¤O²£«~¡G

1. ¯×ªÕ¨xÃÄ¡GSNP-610 ©M SNP-630 ¦U¦³ÀuÂI¡A¥Ø¼Ð¬°¥þ²y±ÂÅv

2. ¤îµhÃÄ(OTC): SNP-810, ¥Ø¼Ð¬°¬ü°ê¤Î¥þ²y±ÂÅv

3. ¤îµhÃÄ(³B¤èÃÄ): SNP-830 ¤Î SNP-840, ¦b°Êª«¤W¬Ò¦³¥¿­±ªºµ²ªG¡A¥Ø¼Ð¬°¥þ²y±ÂÅv

=============================================================================

*****************************************************************************

¥Ø«e¤½¥q»P°ê»Ú¤j«¬Ãļt¥¿¦b½Í§Þ³N±ÂÅv©M¦X§@­p¹º

§Ú¬Ý¹L¤½¥q©xºô©M©Ò´£¨Ñªº¸ê®Æ¡Aı±o¤½¥q«Ü¥Î¤ß¦b¸gÀç¡A¦Ó¥B¸ê®Æ¤]«Ü¸Ô²Ó

¹ï¤½¥qµo®i«Ü¦³¦Û«H¡A¥¼¨ÓªÑ»ù­È±o´Á«Ý¡A¦³¾÷·|¬O ¤U¤@­Ó ¦X¤@ ÄÆªÑ

-----------------------------------------------------------------------------

¥H¤W¸ê®Æ ³£°Ñ¦Ò ªÑªF·|ij¨Æ¿ý.pdf ©M ¤½¥q©xºô (¦³¿³½ìµÛÅwªï¦A²`¤J¬ã¨s»P°Q½×)

·|­û:ROGER588910148151µoªí®É¶¡:2025/6/3 ¤W¤È 08:04:48²Ä4156½g¦^À³
[¨xµw¤Æ]ªº²Ä¤@½u³Ð·s¦A¥ÍÀøªk?

MASHÃĪ«Ävª§ªÌ¦h¡A¥i¯à5¦~¤º·|·s¼W´X¤ä¤W¥«·sÃÄ¡A¦ý³ÌÃø°Ùªº¡§µw°©ÀY¡¨-F4ªì´Á¨xµw¤Æ(¥NÀv¨xµw¤Æ)¤~¬O³Ì¤jªºÂê÷®w!

·|­û:ROGER588910148151µoªí®É¶¡:2025/6/3 ¤W¤È 07:52:37²Ä4155½g¦^À³
2025.5.14---GSKªá20»õ¬ü¤¸¶RFGF21ÃĪ«

2025.2.11--§¨Ó¥¸ 6.25»õ¬ü¤¸Äâ¤âÁú°êOlix §ðMASH siRNAÀøªk(Á{§É¤@´Á¤¤)

2024.4.22-¦ÊÆF¨Î¡]Boehringer Ingelheim¡^»P½ê¥Û¥ÍÂå¹F¦¨¨óij...3500 ¸U¬ü¤¸ªº¹w¥I´Ú.»ù­È¶W¹L10»õ¬ü

¤¸ªº¦X§@¨óij¡A¦@¦P¬ãµoªvÀøºC©Ê¨x¯f¡]CLDs¡^¡A¨Ò¦p¥NÁ©ʯתըxª¢¡]MASH¡^¨xµw¤Æªº²Ä¤@½u³Ð·s¦A

¥ÍÀøªk¡C

2024.1.4-¦ÊÆF¨Î®ï®æ¿« 20»õ¬ü¤¸Äâ¤â¤¤°ê·ç³ÕsiRNAÀøªk§ðNASH

--------------------------------------------------------------------------------------

¥H¤W4¥ó¬O2024~2025¦~MASHÃĪ«¦X§@±ÂÅv®×(©Î¦³¿òº|¨S¦C)

·|­û:ROGER588910148151µoªí®É¶¡:2025/6/2 ¤W¤È 11:22:30²Ä4154½g¦^À³
·|­û:ROGER588910148151µoªí®É¶¡:2025/6/2 ¤W¤È 09:05:28²Ä4150½g

...3.[ÄAÂЦʦ~»{ª¾]½×¤åµoªí:HSCªº«DÅÖºû¤Æ¥\¯à¤~¬Oºû«ù¨xŦíºAªºÃöÁä....

---------------------------------------------------------------------

ªYÄ£¥h¦~²Ä8©¡¯×ªÕ¨xª¢ÃĪ«¶}µo°ª®p·|¸ê®Æ

Multiple Effects of SNP-6 series in MASH

www.sinewpharma.com/Upload/download/20240923-SINEW.pdf

¤@¼Ë¼C«üHSC¬¡¤Æ-½¦­ì³J¥Õ¨I¿n[§ÜÅÖºû¤Æ]¡A¦ô­p¦¹¨è¥¿¥[§Ö±´¨s[ÄAÂЦʦ~»{ª¾]½×¤åªº[HSC«DÅÖºû¤Æ¥\¯à]¾÷¨î!

·|­û:ROGER588910148151µoªí®É¶¡:2025/6/2 ¤W¤È 09:46:02²Ä4153½g¦^À³
[ÄAÂЦʦ~»{ª¾]½×¤åªº¨xŦ¦A¥Í«OÅ@[·s¿oªº¾ãÅéªvÀø¤èªk]©Î¦³¥i¯àªvÀøMASH [¥¢¥NÀv¨xµw¤Æ]F4±ß´Á±wªÌ???

-----------------------------------------

±q¦L«×µoªíªº¤þ¨xªv¡«áªº [¥¢¥NÀv¨xµw¤Æ]±wªÌ¼Æ¾Ú¡A

¤£½×½Ö®a¥ý®³¨ìMASH[¥NÀv¨xµw¤Æ]F4ÃÄÃÒ¡A«áÄò´N·|¬D¾Ô [¥¢¥NÀv¨xµw¤Æ]±ß´ÁÃÄÃÒ!

·|­û:ROGER588910148151µoªí®É¶¡:2025/6/2 ¤W¤È 09:38:39²Ä4152½g¦^À³
[ÄAÂЦʦ~»{ª¾]½×¤åªº¨xŦ¦A¥Í«OÅ@[·s¿oªº¾ãÅéªvÀø¤èªk]©Î¦³¥i¯àªvÀø[¥¢¥NÀv¨xµw¤Æ]???

³Ìªñ¦L«×ªº¤@¶µHCV(C¨x/¤þ¨x)§Ü¯f¬rªvÀø¬ã¨sªí©ú¡A¦³¨Ç[¥¢¥NÀv¨xµw¤Æ]F4±ß´Á±wªÌ¦bªv¡«á¤]¥i¥H«ì´_¦¨[¥NÀv¨xµw¤Æ]F4ªì´Á!

2024.3.25-www.sciencedirect.com/science/article/abs/pii/S0016508524053599

¤wÃÒ©ú¡A¹ï HCV ¶i¦æ¦³®ÄªvÀø¥i¨Ï¨xµw¤ÆÁ{§É¶¥¬q®ø°h¡A¨ä¤¤¤À§O¦³ 36% ©M 39% ¹F¨ì Child A ©M B ª¬ºA¡C

-----------------------------------------------------------------------------------------

¤þ«¬¨xª¢¯f¬r(HCV¡^·P¬V¨x²Ó­M¡A³z¹L¬¡¤Æ¨x¬Pª¬²Ó­M¡]HSC¡^©M¨x²Õ´¤¤²Ó­M¥~°ò½èªº¹L«×¨I¿n¡A«P¶i¨xÅÖºû¤Æ¡C

¨xµw¤ÆªºÁ{§É¯fµ{¥i¤À¬°¨â­Ó¶¥¬q¡A²Ä¤@¶¥¬qºÙ¬°¥NÀv©Ê¡]Child-Pugh A¯Å¡^¡A²Ä¤G¶¥¬q«h¬O¥¢¥NÀv©Ê¡]Child-Pugh B¡BC¯Å¡^¡C

·|­û:ROGER588910148151µoªí®É¶¡:2025/6/2 ¤W¤È 09:10:13²Ä4151½g¦^À³
Saroglitazar¤@ºØÂù­« PPAR £\/£^ ¿E°Ê¾¯
·|­û:ROGER588910148151µoªí®É¶¡:2025/6/2 ¤W¤È 09:05:28²Ä4150½g¦^À³
·|­û:ROGER588910148151µoªí®É¶¡:2023/7/6 ¤W¤È 10:29:12²Ä3294½g¦^À³·|­û¡G

¥Ø«e(CYP2E1§í¨î--->¿E¬¡PPAR£\<--->¿E¬¡FGF21)³o±ø³q¹D¥i¯à´N¬ONASH¦¨¥\¤§¸ô!?

-------------------------------------------------------------------------------------

1.2020¦~¦L«×®Ö­ã¥þ²y­º´ÚNASHªvÀø·sÃÄSaroglitazar¦b[¦L«×¤W¥«].

2. ¦Ü¤Ö3¤äFGF21ÃĪ«Á{§É¼Æ¾Ú¤£¿ù¡A2025¦~5¤ëGSKªá20»õ¬ü¤¸¶R¤H³yFGF21Ãþ¦üÃĪ«¡C

3.[ÄAÂЦʦ~»{ª¾]½×¤åµoªí:HSCªº«DÅÖºû¤Æ¥\¯à¤~¬Oºû«ù¨xŦíºAªºÃöÁä¡A±NHSC¥­¿Å±qÅÖºû¤ÆÂà¦V¨xŦ¦A¥Í«OÅ@¥Nªí¤@ºØ[·s¿oªº¾ãÅéªvÀø¤èªk]¡C¦p¦P±NNASH§ó¦W¬°MASH[¥NÁÂ¥\¯à»Ùê]¬ÛÃö¯×ªÕ©Ê¨xª¢ªº¨º¯ë¡AªÈ¥¿¾É­P¯e¯fªº¼ç¦b [¥NÁ¯¿¶Ã] ¦ü¥G³Ì¦³Àø®Ä¡A¦Ó¤£¬Oª½±µ¹v¦V±þ¦ºHSC¬¡¤Æ©MÅÖºû¤Æµ¥¦]¤l¡C

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/31 ¤U¤È 10:02:51²Ä4149½g¦^À³
HSC ¬¡¤Æªº¶Àª÷¼Ð·Ç¬O£\-SMA ªºªí¹F!(SNP-630§í¨îÅÖºû¤ÆACTA2(£\-SMA)°ò¦]ªí¹F: P<0.0001)

journals.plos.org/plosone/article?id=10.1371/journal.pone.0082159

HSC¬OÃþµø¶À»ÄÀx¦sªº¥D­n³¡¦ì¡A¥Í²z¤W³B©óÀR¤îª¬ºA¡A¦b¨x·l¶Ë´Á¶¡¡A³y¦å·F²Ó­M·|³vº¥³Q¿E¬¡¡AÄÀ©ñÃþµø¶À»Ä¡A¨ÃÀò±o¦Ù¦¨ÅÖºû²Ó­M¼ËªºÅÖºû¤Æ¡B¦¬ÁY©M¼W´Þªí«¬¡C¦b²Ó­M°ö¾i¤¤¡AHSC ¥i¥H¹ê²{³oºØ³v¨B¿E¬¡¡A±qÀR¤îª¬ºA¡]°ªÃþµø¶À¾J¤ô¥­©M µL£\-SMAªí¹F¡^¸g¹L´ç¿E¬¡ª¬ºA¡]¤¤µ¥Ãþµø¶À¾J©M £\-SMAªí¹F¡^¦A¨ì°ª«×¿E¬¡ª¬ºA¡]§C©ÎµLÃþµø¶À¾J¤ô¥­©M°ª£\-SMAªí¹F¡^

--------------------------------------------------------------------------------------

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/10 ¤U¤È 11:54:29²Ä4059½g¦^À³

­ß­ß¤§¤¤¦Û¦³¤Ñ·N¡A¤@½g[ÄAÂЦʦ~»{ª¾]½×¤å·|µ¹ªYÄ£(SNP-6§í¨îcyp2e1»PTGF-£])±a¨ÓÅå³ß¶Ü?

¦h¶µ¬ã¨sªí©úcyp2e1¹Lªí¹F¬¡¤ÆHSCs

------------------------------------------------------------------------------------

...(HSCs°ª«×´I¶°RSPO3¡AHSCsªº«DÅÖºû¤Æ¥\¯à¤~¬Oºû«ù¨xŦíºAªºÃöÁä¡ARSPO3ªºªí¹F¦bHSCs¬¡¤Æ®É´î¤Ö

-----------------------------------------------------------------------------------------

·|­û:ROGER588910148151µoªí®É¶¡:2023/7/31 ¤W¤È 09:41:30²Ä3340½g¦^À³

¦^ÀY¦A¬Ý¼w°ê®ü¼w³ù¤j¾Çªñ40¦~¨Óªº¬ã¨s¡A¯S§O¦³·PCYP2E1©M¨xÅÖºû¤Æµ{«×¤§¶¡¦s¦b[°ª«×ÅãµÛ]ªº¬ÛÃö©Ê!(ªYÄ£F4¥[ªo)

SNP-630§í¨îÅÖºû¤ÆACTA2(£\-SMA)°ò¦]ªí¹F: P<0.0001

SNP-630§í¨îÅÖºû¤ÆTIMP-1°ò¦]ªí¹F:P<0.01

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/31 ¤W¤È 09:37:19²Ä4148½g¦^À³
ºû¥Í¯ÀA(Vitamin A) ¨ã¦³¤TºØ¥D­n¬¡¤ÆºA¡Gµø¶À¾J¡Bµø¶À»Ä¡Bµø¶ÀîÇ

¤HÅé80%ªººû¥Í¯ÀAÀx¦s¦b¨xŦ¨x¬Pª¬²Ó­MHSC

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/31 ¤W¤È 09:17:23²Ä4147½g¦^À³
1.¸g¹L 10 ­Ó¤ëªºªvÀø¡A¤j¹«¦]°sºë¦Ó­°§Cªº¨xŦµø¶À¾J©Mµø¶À»Ä¿@«×³z¹L CMZ(cyp2e1§í¨î¾¯)ªvÀø«ì´_¨ì¥¿±`

¤ô¥­¡C

2.¥Ñ©ó¨ã¦³¦¨Å}©Ê¡A±wªÌ¥u¯àµu®É¶¡ªA¥ÎCMZ ¡C

CMZ ¦b 10 ¤Ñ¤º¹ï CYP2E1 ªº§í»s§@¥Î³q¹L £\ °Ê­û¨x¯×ªÕ©M­°§C¦å²MÂà®ò酶¬¡©ÊÅãµÛ§ïµ½¤F ALD¡C

CMZ ¦b 10 ¤Ñ¤º¹ï CYP2E1 ªº§í»s§@¥Î³q¹L £\ °Ê­û¨x¯×ªÕ©M­°§C¦å²MÂà®ò酶¬¡©ÊÅãµÛ§ïµ½¤F ALD¡C

------------------------------------------------------------------------------------

ªYÄ£SNP-6ªº§C°Æ§@¥Î¤]¨S¦³¦¨Å}©Ê°ÝÃD¡A±wªÌ¥iªø®É¶¡ªA¥Î!!!

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/31 ¤W¤È 09:09:08²Ä4146½g¦^À³
¦³¤F[ÄAÂЦʦ~»{ª¾]½×¤å¡A¦A¦^ÅU¼w°êªºCMZ¤HÅéÁ{§É¸ÕÅç¼Æ¾Ú:¦í°|µ²§ô®ÉªA¥Î CZP ªº±wªÌ¬Û¤ñ¡ACMZ ±wªÌªº¦å²MAST( P < 0.004)©MALT¬¡©Ê ( P < 0.0006) ÅãµÛ­°§C¡C

ªYÄ£SNP-6¦¨¥\²v¦A¸õ°ª!

----------------------------------------------------------------------------------------

ROGER588910148151 µoªí®É¶¡:2022/10/29 ¤U¤È 06:17:24²Ä 2646 ½g¦^À³

¼Ú·ùÁ{§É¸ÕÅçµù¥U www.clinicaltrialsregister.eu/ctr-search/trial/2012-005730-11/DE

¼w°êCMZ(CYP2E1§í»s¾¯)Á{§É¸ÕÅçÅãµÛ§ïµ½¤FALD°sºë©Ê¨xª¢¡A¦ý¬O[¥Ñ©óCMZ¨ã¦³¦¨Å}©Ê¡A¦]¦¹¤£¯àªø´ÁªA¥Î¡C]

------------------------------------------------------------------------------------------

2022.3¤ë30¤é °sºë©Ê¨x¯f±Ô¨Æ¦^ÅU¡G±qÅÖºû¤Æ¨ìÀù¯g

...ªñ 40 ¦~¨Ó¡A§Ú­Ì¹êÅç«Ç¤@ª½¦b¬ã¨s²Ó­M¦â¯À P4502E1 (CYP2E1) ¦b ALD ©M°sºë¤¶¾Éªº­PÀù§@¥Î¤¤ªº§@¥Î¡C¦¹¥~¡ACYP2E1 ¦b ALE ¤¤ªº§@¥Î¦b CYP2E1 ºV°£¤p¹«¤¤±o¨ì¤F¥O¤H¦L¶H²`¨èªºÃÒ©ú¡A¤£¶ÈÅã¥Ü¥XºC©Ê¶¼°s«á®ñ¤ÆÀ³¿E¼Ð»xª«ªºÅãµÛ­°§C¡A¦Ó¥BÁÙÅã¥Ü¥X¨xŦ²Õ´¾ÇªºÅãµÛ§ïµ½ ¡C¥t¤@¤è­±¡A¹L«×ªí¹F CYP2E1 ªº°Êª«ªí²{¥X ALD ªºÄY­«µ{«×¼W¥[ ¡CCMZ¡]¤@ºØ¯S²§©Ê CYP2E1 §í»s¾¯¡^¹ï CYP2E1 ªº§í¨î¤]§ïµ½¤F°Êª«¹êÅ礤ªº ALD ¡C

³o¥O¤H«HªA¦a±j½Õ¤F CYP2E1 ¦b­PÀù§@¥Î¤¤ªº§@¥Î¡C

----------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2023/5/25 ¤U¤È 06:24:07²Ä 3223 ½g¦^À³

³Ì«á¡A³Ìªñªº¤@¶µÀH¾÷Á{§É¸ÕÅç¥O¤H«HªA¦aÃÒ©ú¡ACMZ ¦b 10 ¤Ñ¤º¹ï CYP2E1 ªº§í»s§@¥Î³q¹L £\ °Ê­û¨x¯×ªÕ©M­°§C¦å²MÂà®ò酶¬¡©ÊÅãµÛ§ïµ½¤F ALD¡C

2022.12.22

academic.oup.com/alcalc/article-abstract/58/2/134/6957276?redirectedFrom=fulltext

¤èªk

¶}©ñ¼ÐÅÒ¡BÀH¾÷¹ï·ÓÁ{§É¸ÕÅç¡A¦®¦b¬ã¨s CYP2E1 §í¨î¬O§_¯à§ïµ½±µ¨ü°sºë¸Ñ¬rªvÀø (ADT) ªº°sºë¨Ï¥Î»Ùê±wªÌªº ALD¡C¤J°|®É±wªÌªº¦å²M¤Ñ¥V®ò»Ä®ò°òÂಾ酶 (AST) ¬¡©Ê¥²¶·¶W¹L¥¿±`¤W­­ªº¨â­¿¡A¨Ã¥B®Ú¾ÚÅÖºû±½´y­È <12 kPa ©w¸q¬°«D¨xµw¤Æ¡C60 ¦W±wªÌ¥H 1:1 ªº¤ñ¨Ò³QÀH¾÷¤À°t¨ì¨Ï¥Î CMZ ©Î´â©Ô¦è¯S (CZP) ¶i¦æ 7-10 ¤Ñªº ADT¡CCYP2E1 ¬¡©Êªº´âÐü¨F©v´ú¸Õ¦b¤J²Õ®É©M¬ã¨s´Á¶¡ªº¨â­Ó®É¶¡ÂI¶i¦æ¡C

µ²ªG

ADT ÅãµÛ§ïµ½¤F¨â²Õªº¨x¯×ªÕÅܩʡ]¨ü±±°I´î°Ñ¼Æ¡^¡C »P CZP ²Õ¡]- 13.9%¡F273 ¡Ó 38 dB/m ¹ï¤ñ 317 ¡Ó 39 dB/m¡FP < 0.0001¡^¡C ¥¿¦p¤w¸g³ø¾Éªº¨º¼Ë¡A»P¦í°|µ²§ô®ÉªA¥Î CZP ªº±wªÌ¬Û¤ñ¡ACMZ ±wªÌªº¦å²M AST ( P < 0.004) ©M¤þ®ò»Ä®ò°òÂಾ酶 (ALT) ¬¡©Ê ( P < 0.0006) ÅãµÛ­°§C¡Cµo²{ AST ( P = 0.023)¡BALT ( P = 0.009)¡BGGT ( P = 0.039) ©M CAP ¤§¶¡¦s¦bÅãµÛ¬ÛÃö©Ê¡C

µ²½×:³o¶µ¬ã¨sªí©ú¡ACMZ §ïµ½¤F¤HÃþ ALD ªºÁ{§É¥Íª«¼Ð»xª«¡A³o«Ü¥i¯à¬O¥Ñ©ó¨ä¹ï CYP2E1 ªº§í»s§@¥Î¡C¥Ñ©ó¨ã¦³¦¨Å}©Ê¡ACMZ ¥u¯àµu®É¶¡ªA¥Î¡A¦]¦¹»Ý­n¨ä¥L CYP2E1 §í»s¾¯¨ÓªvÀø ALD¡C

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/30 ¤U¤È 10:53:10²Ä4145½g¦^À³
¦³½ìªº¨Æ!

Nature¡G颠ÂЦʦ~认ª¾¡I¨x脏纤维¤Æ¤¸¤¿³º¬O¥N谢¦A¥Í总«ü挥

¦b°Êª«¹êÅ礤¡A§½³¡ª`®gRSPO3©`¦ÌÁû²É¨ÏCCl4·l¶Ë¤p¹«ªº [¦A¥Í³t«×]´£¤É2.3­¿¡A³o­Ó¬ð¯}¬°¨x°IºÜªvÀø±a¨Ó¤F¥þ·s¥i¯à¡C

---------------------------------------------------------------------------------

ROGER588910148151µoªí®É¶¡:2025/5/24 ¤U¤È 12:39:59²Ä4120½g¦^À³

¦³½ìªº¬O¡A¬ã¨sÆ[¹î¨ìCYP2E1§í¨î¥i¥H [¥[³t]AILI(APAP»¤¾É©Ê¨x·l¶Ë)±ß´Áªº [¨xŦ«ì´_]¡C

¦ýµ²½×¥u¬Oªì¨Bªº¡A¨xŦ¦A¥Í¥Íª«¼Ð°OªºÅܤƤ´¦³«Ý¶i¤@¨B½T©w¡C

---------------------------------------------------------------------------------

±N HSC ¥­¿Å±qÅÖºû¤ÆÂà¦V¨xŦ«OÅ@¥i¯à¥Nªí¤@ºØ·s¿oªº¾ãÅéªvÀø¤èªk

CYP2E1§í¨î¥[³t¨xŦ«ì´_¡A±N¨x·l¶ËÂà¦V¨xŦ«OÅ@?(SNP-610»PSNP-630ÃĪ«?)

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/30 ¤U¤È 10:48:32²Ä4144½g¦^À³
ªYÄ£SNP-6ÃĪ«¾÷¨î¥¿¤¤[ÄAÂЦʦ~»{ª¾]½×¤åªº2­Ó关键调±±节点:TGF-£] »P 维¥Í¯ÀA(视黄¾J¡B视黄îÇ¡B视黄»Ä)

1.¤@¸s´¿³QÂå¾Ç¬É§¯Å]¤Æªº²Ó­M¡A³º¬O¾Þ±±¨xŦ©R¹BªºÁô§Î¾Þ½L¤â¡C

¤HÅ餺ªºÅܧΪ÷­è¡GHSCsªº´¼¼z¤Á´«¼Ò¦¡

ÃöÁä½Õ±±¸`ÂI¥]¬A¡G TGF-£]3¥i¨ÏHSCsªºRSPO3¤Àªc´î¤Ö92% / ºû¥Í¯ÀAÀx¦s¶q§C©óìH­È®É¡AHSCs¦Û°Ê¶i¤J

ÅÖºû¤Æ¼Ò¦¡

³o¨Çµo²{¬°¶}µo´¼¼z«¬ÃĪ«´£¨Ñ¤FÂŹϡG³z¹Lºû«ùHSCsªººû¥Í¯ÀAÀx³Æ¡A©Î³\¯àªø´Á«O«ù¨ä­×´_¥\¯à¦Ó¤£¤Þµo

ÅÖºû¤Æ¡C

2. pubmed.ncbi.nlm.nih.gov/23543859/

CYP2E1±Nµø¶À»Ä©Mµø¶À¾J­°¸Ñ¬°·¥©Ê¥NÁª«¡A¥NÁ¾ɭPµø¶À»Äªº¬y¥¢....

....¸g¹L 10 ­Ó¤ëªºªvÀø¡A¤j¹«¦]°sºë¦Ó­°§Cªº¨xŦµø¶À¾J©Mµø¶À»Ä¿@«×³z¹L CMZ(cyp2e1§í¨î¾¯)ªvÀø«ì´_¨ì¥¿±`¤ô¥­¡C

--------------------------------------------------------------------------------------

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/10 ¤U¤È 11:54:29²Ä4059½g¦^À³

­ß­ß¤§¤¤¦Û¦³¤Ñ·N¡A¤@½g[ÄAÂЦʦ~»{ª¾]½×¤å·|µ¹ªYÄ£(SNP-6§í¨îcyp2e1»PTGF-£])±a¨ÓÅå³ß¶Ü?

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/30 ¤W¤È 08:34:18²Ä4143½g¦^À³
§¨Ó·sÃĤý¦£µÛ¶}«õ¥¼¨Ó10¦~ªºª÷Äq¡AJNJµJÀYÄêÃBµÛ¶D³^¯}²£¡C

2025.4.1--¬ü°êªk°|»é¦^±j¥Í(JNJ.US)100»õ¬ü¤¸À¦¨à²n¨­¯»©M¸Ñ¨óij

¬ü°ê¯}²£ªk°|»é¦^±j¥Í¤½¥q(JNJ.US)´£¥Xªº100»õ¬ü¤¸©M¸Ñ´£Ä³¡A¥H²×¤î¼Æ¥H¸U­p«ü±±¨äÀ¦¨à¯»¤Î¨ä¥L·Æ¥Û¯»²£«~·|¾É­P§Z±_Àùªº¶D³^¡A¬°¤½¥qªº[¯}²£µ¦²¤]²Ä¤T¦¸¦bªk®x¤W¥¢±Ñ¡C

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/30 ¤W¤È 08:24:35²Ä4142½g¦^À³
¤@°ï¶D³^«ß®v«ùÄò©Û¦¬Tylenol¨x·l¶Ë¥ó¼Æ¡A¤£©ñ¹LÁÈ¿ú¾÷·|!

www.sinklaw.com/mass-torts/tylenol/

¥Ø«eªº¬ã¨s¤wÃÒ¹ê¡A¹L¶qªA¥Î¹ï¤AñQ®ò°ò×ô¡]®õ¿Õµ¥«D³B¤èÃĤ¤¨Ï¥Îªº¤Æ¾Çª«½è¡^·|¾É­P¨xŦ¶W­t²ü¹BÂà¨Ã³y¦¨¤£¥i°fÂ઺·l®`¡C

³\¦h¤HÁnºÙ¡A¾¨ºÞ¥L­Ì¿í´`¤F²£«~»¡©ú¡A¦ý¦bªA¥Î®õ¿Õ«áÁÙ¬O¾D¨ü¤F¨x·l¶Ë¡C

³\¦h¤HÁnºÙ¡A¾¨ºÞ¥L­Ì¿í´`¤F²£«~»¡©ú¡A¦ý¦bªA¥Î®õ¿Õ«áÁÙ¬O¾D¨ü¤F¨x·l¶Ë¡C

³\¦h¤HÁnºÙ¡A¾¨ºÞ¥L­Ì¿í´`¤F²£«~»¡©ú¡A¦ý¦bªA¥Î®õ¿Õ«áÁÙ¬O¾D¨ü¤F¨x·l¶Ë¡C

¦pªG±z¦bªA¥Î®õ¿Õ«á¥X²{¨x·l¶Ë¡A±z¥i¯à¦³¸ê®æ¥[¤J®õ¿Õ²£«~»s³y°Ó McNeil Consumer Healthcare ªº¶°Åé«IÅv¶D³^¡C¨Ó¦Û³ìªv¨¯§J (George Sink) »«¦{¶Ë®`«ß®v¨Æ°È©Òªº«n¥dù¨Ó¯Ç¦{®õ¿Õ¶D³^«ß®v¥i¥HÀ°§U±z³B²z®×¥ó¡C

----------------------------------------------------------------------------------------

2017.2.23- ±j¥Í¤½¥q´N®õ¿Õ®¶D³^¹F¦¨©M¸Ñ

»«¦{¶O«°¡X®õ¿Õ®¶D³^®×¤w¹F¦¨·sªº©M¸Ñ¡C±j¥Í¤½¥qºX¤Uªº McNeill Consumer Healthcare ©ó 2017 ¦~ 2 ¤ë 10 ¤é¦P·N¥H¥¼´¦ÅSªºª÷ÃB¸Ñ¨M 200 ¦h°_®×¥ó¡C®Ú¾Úªk®x¤å¥ó¡A¸Ó¨óij¡§«Ø¥ß¤F¤@­Ó¥þ²y¨p¤H©M¸Ñ­p¹º¡A¥H¸Ñ¨M­ì§i°w¹ï McNeil ³Q§iªº®õ¿Õ¯Á½ß¡]µL½×¬O§_¤w´£°_¡^¡A¨Ã¥B­ì§i¤w¦P·N³q¹L¸Ó­p¹º¸Ñ¨M¨ä®õ¿Õ¯Á½ß¡C¡¨

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/30 ¤W¤È 08:11:23²Ä4141½g¦^À³
¥­¥­Ãl¬O[¤AñQÓi×ô]¡A«ö«ç¥ìµL¬r¡A§A¦³¬r¡C

¶D³^«ß®v¾ß¨ìºj¡A¤£§âJNJ¥´¦¨¸ÁºÛ¤~©_©Ç!

---------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/6/26 ¤U¤È 04:06:47²Ä 1247 ½g¦^À³

¶D³^«ß®v¹ï±j¥Íªº¯Á½ß¥D±i:

Tylenol ªº³]­p©M¾P°â¦³¯Ê³´¡A¨Ã¥B³B©ó¡§¦³¯Ê³´¥B¤£¦X²zªº¦MÀIª¬ºA¡¨

[¥i¨Ñ®ø¶OªÌ¨Ï¥Îªº²£«~À³¸Ó¨ã¦³¦X²zªº¦w¥þÃä»Ú]=½¦¨¥Õ¸Ü´N¬O:APAPªºªvÀø¾¯¶q»P¦w¥þ¾¯¶qªº¾¯¶q½d³ò¤Ó¯¶¡C

---------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/9 ¤W¤È 09:16:38²Ä 3790 ½g¦^À³

¤jÃļt¡u¤U¤£¤F¥x¡v§óÁ}Ãø¦a¤@¤Ñ¡AÅý¶D³^«ß®v¾ß¨ìºj¡A¯à´Á«Ý¤£µo¥Í¤j¨Æ???

¶D³^«ß®v/®ø¶OªÌ/¾ÇªÌ/µû½×®a/ªk©x¦b½æ³õ¬[¤W¬Ý¨£SAFETYNADOL(µL¨x¬r)¡A¹j¾ÀªºTylenol(¦³¨x¬r)

·|­û:dk10140377µoªí®É¶¡:2025/5/29 ¤U¤È 02:11:15²Ä4140½g¦^À³
±Í¤H¤Ó肤浅¤F

þ÷来¤]¤Ó¦³钱¤F¡A§Æ±æ¤]来个10e镁

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/29 ¤W¤È 11:43:49²Ä4139½g¦^À³
§¨Ó¤½¥q­º®u¬ì¾Ç©MÂåÀø©xDan Skovronsky: §A»Ý­n°lÀH§A©Òª¾¹Dªº10¦~«á·|¬y¦æªº¨Æª«!!!

¤îµhÃÄ¥«³õ³Q»{¬°¬OÄ~GLP-1´îªÎÃĤ§«áªº¤U¤@­Ó¤d»õ¬ü¤¸ª÷Äq!!!

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/29 ¤W¤È 11:37:13²Ä4138½g¦^À³
§¨Ó¤½¥q­º®u¬ì¾Ç©MÂåÀø©xDan Skovronsky: §A»Ý­n°lÀH§A©Òª¾¹Dªº10¦~«á·|¬y¦æªº¨Æª«!!!

2023.3.2---§¨Ó»PConfoñ¸p¥~©P¯kµhªvÀøÃĪ«¡A¹w¥I 4000 ¸U¬ü¤¸¡A¨½µ{ª÷5.9 »õ¬ü¤¸¡C

-------------------------------------------------------------------------------

2023.6.5-¡u§Ú­Ì¦b°f¬y¦Ó¤W¡v¡G§¨Ó¬°¦ó¹Á¸Õ·s¤èªk¹ï§Ü¯kµh

¡u³o´N¬O§Ú­Ì·Q­nªº¡A¡v§¨Ó­º®u¦æ¾Pªø»¡¡C

....FDA §½ªøÃ¹§B¯S¡P¥d§Q¤Ò¡§´¿´N¹ªÀy»sÃĤ½¥q§ë¸ê¤îµhÃݵ¥X¹L¦³§Æ±æªºµû½×¡¨

´µ¬ì¨U¶©´µ°ò»¡¡G¡u³o­Ó¦æ·~ªº«Ü¦h¤H¥u¬O°lÀH¼öªùªº¨Æª«¡C¡v¦ý³o¤w¸g±ß¤F10¦~¡C§A»Ý­n°lÀH§A©Òª¾¹Dªº10¦~«á·|¬y¦æªº¨Æª«¡C°µ¨ì³o¤@ÂIªº³Ì¨Î¤è¦¡¬OÅý¥¦¦¨¥\¡A¼g¤U¥¼¨Ó¡X¡X³o´N¬O§Ú­Ì¦b³o¸Ì§V¤O°µªº¨Æ±¡¡C ¡v

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/29 ¤W¤È 10:26:10²Ä4137½g¦^À³
¿ú¦h¨ìº¡¥X¬Ö¤l¨Ó¤F~¶¡±µ§â[¿Õ©M¿Õ¼wCEO]¿å¤U¥x!

2025.4.25-¤j¬~µP¡I§¨Ó¤fªA´îªÎÃÄorforglipron®ÄªG½VÀ£¿Õ©M¿Õ¼w ¥«­Èöt¯}8000»õ¦¨·sÃĤý

·|­û:dk10140377µoªí®É¶¡:2025/5/29 ¤W¤È 10:16:10²Ä4136½g¦^À³
©Ò¥H¦pªG§¨Ó¦babcd¨½­±¡A¥NªíµVµV¤S¤Ö¤F¤@®a¡K应该没这¦³钱©ã两®a§a

©Ò¥H¦pªG§¨Ó¤£¦babcd¨½­±¡A¥Nªíµ{«×¤Ó®t¬Ý¤£¤W²´¡K

简¨¥¤§¡A¬O负­±¬Ý«Ý¡C°ß¤@´N¬Oabcd给¥X­«击¥´脸ª©¤W¤£¬Ý¦nªº¦U¦ì¬Ý­¾¡A¤]还¬Ý¦nªº¤@个­¦­¦©[°®

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/29 ¤W¤È 09:41:14²Ä4135½g¦^À³
C¤½¥q¡Gµû¦ô¤¤ / D¤½¥q¡GÂù¤è¤w¥æ´«CDA¡A¥¿·¾³q¯óÀÀTerm Sheet¤¤¡C

ÁÙ¨S¦¨¥\±ÂÅv¤½¥¬¡A¤Ñ¾å±oABCD¬O¨º®a?

·|­û:dk10140377µoªí®É¶¡:2025/5/29 ¤W¤È 09:34:15²Ä4134½g¦^À³
¤pªYªYª¾¦W«×¤£°ª还¬O卖¬Û¤£¦n??

¤£¦bþ÷来ªº¹p达¨½­±??

================

2025.5.28-§¨Ó»¨ÂY¤Q»õ¬ü¤¸©ãª`¼ç¤O¤îµh·sÃÄ(«D¾~¤ùÃþ¤îµhÃĶ}µoªÌSiteOne)

....­Ô¿ïÃĪ«§Y±N¶i¤J²Ä¤G´ÁÁ{§É¸ÕÅç¡A¸ÓÃĪ«³z¹LªýÂ_NaV1.8¶u³q¹D¨ÓªvÀø¯kµh¡C

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/29 ¤W¤È 08:18:06²Ä4133½g¦^À³
1.¤îµhÃÄ¥«³õ³Q»{¬°¬OÄ~GLP-1´îªÎÃĤ§«áªº¤U¤@­Ó¤d»õ¬ü¤¸ª÷Äq¡A«e10¦Wªº»sÃĤ½¥q¤]°Ñ»P¨ä¤¤(½÷·ç¡B§

¨Ó¡B¸¯Äõ¯À¥v§J¡B±j¥Í....¡C

2.¯kµhÃĪ«¬ãµoºÞ½u¥D­n¥Ñ¤p«¬¤½¥q¥D¾É¡A¦Ó¤p¤½¥q¬ãµoªº¯kµhÃĪ«³Ì«á´N¬O¸ò¤j¼t¦X§@¶}µo±ÂÅv

----------------------------------------------------------------------------------

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/14 ¤U¤È 10:04:39²Ä4068½g¦^À³

Top Analgesics Companies(¥þ²y³»¦y10®aÂíµhÃĤ½¥q)

½÷·ç¡B§¨Ó¡B¸¯Äõ¯À¥v§J¡B±j¥Í....

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/29 ¤W¤È 07:34:08²Ä4132½g¦^À³
¥Ø«e¯kµhÃþ·sÃĶ}µo±q [I´Á¨ì®Ö­ã]ªº¾ãÅ馨¥\¾÷²v¬° 0.7%¡A¦Ó©Ò¦³¯e¯f»â°ì·sÃÄ­Ô¿ï­pµeªº¦¨¥\¾÷²v¬° 6.5%¡C

¦pªG§âÁ{§É[«e]¶}µo¥¢±Ñªº®×¥ó¤]¯Ç¤J²Î­p¡A¯kµhÃþ·sÃĦ¨¥\¾÷²v®£Áͪñ0!

----------------------------------------------------------------------------------------

2023-The State of Innovation in Pain and Addiction¯kµh©M¦¨Å}»â°ìªº³Ð·s²{ª¬

§@ªÌ¡GDavid Thomas¡A¯S³\ª÷¿Ä¤ÀªR®v ©M¬d¼w¡P­³¶ëº¸ ¥Íª«²£·~¤ÀªR

go.bio.org/rs/490-EHZ-999/images/BIO_The_State_of_Innovation_in_Pain_and_Addiction_2017_2022.pdf

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/28 ¤U¤È 08:59:06²Ä4131½g¦^À³
·|­û:ROGER588910148151µoªí®É¶¡:2025/5/28 ¤U¤È 08:16:15²Ä4129½g¦^À³

¤îµhÃÄ0.7%¦¨¥\²v¤~¬OÃĪ«¶}µo³Ì¥i©Èªº¤j¿ú§|!!!

-----------------------------------------------------------------------------------

¸Õ°Ý0.7%¦¨¥\²v¡A¨º®a¤j¼t°ªºÞ¤£·|µn®É­Ë©â¤F¤@¤f®ð¡A²D¤F¥bºI?

Àù¯gÃÄ5.1%%¦¨¥\²v / ºë¯«¯e¯fÃĪ« 6.2%%¦¨¥\²v.

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/28 ¤U¤È 08:37:45²Ä4130½g¦^À³
AI ºK­n

2023¦~¥þ²y(DSP)¦a¶ë¦ÌªQÁC»Ä¶u¥«³õ³W¼Ò¹F11»õ¬ü¤¸¡C IMARC ¶°¹Î¹w­p¡A¨ì 2032 ¦~¡A¥«³õ³W¼Ò±N¹F¨ì 15 »õ¬ü¤¸¡A2023-2032 ¦~´Á¶¡ªº½Æ¦X¦~¼Wªø²v¹w­p¬° 4.20%¡C

----------------------------------------------------------------------------------

¥x·LÅéTLC599»ù­È6.7»õ¬ü¤¸¡A¥i±¤¸Ñª¼¥¢±Ñ!

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/28 ¤U¤È 08:16:15²Ä4129½g¦^À³
¤îµhÃÄ0.7%¦¨¥\²v¤~¬OÃĪ«¶}µo³Ì¥i©Èªº¤j¿ú§|!!!

1. ¥x·LÅé¥H·L¯×Åé§Þ³N©µªøDSPÃþ©T¾JÃÄ¥N°Ê¤O¾Ç¨Ã¼W±jDSP©è¹F±w³Bªº¾÷²v----TLC599»ù­È6.7»õ¬ü¤¸!

2022.6.13-¥x·LÅé«Å¥¬¡AºX¤U [ªø®Ä½wÄÀ]°t¤èÃö¸`ª¢¤îµhÃĪ« TLC599¡A»P°ê»Ú»sÃĤj¼t Endo

International plc ñ­q°Ó·~¤Æ¦X¬ù¡A¥x·LÅé±N¥iÀò±o¨½µ{¸Oª÷ 6.7 »õ¬ü¤¸

2.§¨Ó¥H2»õ¬ü¤¸­º¥I¡B15.8»õ­ùµ{ª÷Àò±o¦X§@¶}µoÅvTanezumab--->ªvÀø°©Ãö¸`ª¢ªº¤îµhÁ{§É¥¢±Ñ!

----------------------------------------------------------------------------------------

·|­û:ROGER588910148151µoªí®É¶¡:2025/4/14 ¤U¤È 12:26:02²Ä4038½g¦^À³

³Ì·s¸ê®ÆÅã¥Ü¡A¤îµhÃÄ(0.7%)¤~¬O¬ãµo¦¨¥\²v³Ì§C! (Àù¯g 5.1%¡^

---------------------------------------------------------------------------------------

2016.7.6-¸Ñª¼¨Æ¥ó«á¬Ý·sÃĬãµoªº¦¨¥\²v

·sÃĬãµo¦¨¥\²v¸û§Cªº¤­Ãþ¯e¯f¬°¡GÀù¯g¡]5.1%¡^¡Bºë¯«¯e¯f¡]6.2%¡^¡B¤ß¦åºÞ¯e¯f¡]6.6%¡^¡B¯«¸g¤º¬ì¯e¯f¡]8.4%¡^¡B¦ÛÅé§K¬Ì¯e¯f¡]11.1%¡^¡A

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/28 ¤U¤È 04:19:54²Ä4128½g¦^À³
®Ú¾ÚMordor intelligence½Õ¬dÅã¥Ü¡A2021¦~¥þ²y¯kµhºÞ²z¥«³õ»ù­È794»õ¬ü¤¸¡A¹w­p¨ì2027¦~±N¼Wªø¦Ü1207»õ¬ü¤¸¡A½Æ¦X¦~¼Wªø²v¬°7.39%¡A¦]¦¹ÂíµhÃÄ¥«³õ³Q»{¬°¬OÄ~GLP-1´îªÎÃĤ§«áªº¤U¤@­Ó¤d»õª÷Äq¡C

---------------------------------------------------------------------------

1.¥H¤W³æ¦ì:¤d»õ¬ü¤¸

2. 2013¦~§¨Ó¥H2»õ¬ü¤¸­º¥I¡B15.8»õ­ùµ{ª÷Àò±o¦X§@¶}µoÅvTanezumab(¤îµhÃÄ)¡C

§¨Ó¬Q¤Ñ¯{10»õ¬ü¤¸¦A¾Ô¤îµhÃÄ¥«³õ~

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/28 ¤U¤È 04:13:18²Ä4127½g¦^À³
镇µh药¥«场³Q认为¬O继GLP-1ú£ªÎ药¤§¦Zªº¤U¤@个¤d亿ª÷矿¡C

2024.6.21-¯kµh¥«场 ¤U¤@个¤d亿¡§ª÷矿¡¨

bydrug.pharmcube.com/news/detail/ef93507777141c6fa55cb443ae904df9

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/28 ¤U¤È 03:08:01²Ä4126½g¦^À³
2025.5.28-§¨Ó»¨ÂY¤Q»õ¬ü¤¸©ãª`¼ç¤O¤îµh·sÃÄ(«D¾~¤ùÃþ¤îµhÃĶ}µoªÌSiteOne)

....­Ô¿ïÃĪ«§Y±N¶i¤J²Ä¤G´ÁÁ{§É¸ÕÅç¡A¸ÓÃĪ«³z¹LªýÂ_NaV1.8¶u³q¹D¨ÓªvÀø¯kµh¡C

·|­û:dk10140377µoªí®É¶¡:2025/5/25 ¤U¤È 04:03:25²Ä4125½g¦^À³
请°Ýr¤j

ªYÄ£预¦ô­n¤L­¿¤~¤H¨ú§A弃©O?¦pªG¤è«K¥i¥H给¤p§Ì¤@个参¦Ò

¼W¥[¤@¤U«H¤ß«¢

================================================

­P´I¤§¹D¡A§Ö´N¬OºC¡AºC´N¬O§Ö¡AµLÄߪi°Ê¡A[°í«ù¦Û§Ú§PÂ_]

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/24 ¤U¤È 09:18:33²Ä4124½g¦^À³
ALT§ïµ½¥i¥H§@¬°ªvÀøªº¦³®Ä«ü¼Ð¤§¤@!!!

¬ü°êÂåÀø¶O«Ü°ª¶Q¡A­n«OÀI¤½¥q±Ç¿úÅý±wªÌÄ~ÄòªvÀø¡A±oÅã²{ÃĪ«Àø®Ä!

²Ä1¤ä¤W¥«ªºMASHÃĪ« Resmetirom ªvÀøªº¥Ø¼Ð±Ú¸s/Ä~Äò¥ÎÃÄ /°±¤îªvÀøªº¼Ð·Ç¡C

±M®a¤p²Õ«ØÄ³¡G¦b±w¦³ MASH/NASH ©M¤¤«×¦Ü«D¨xµw¤Æ±ß´ÁÅÖºû¤Æªº±wªÌ¤¤±Ò°Ê©MºÊ´ú Resmetirom ªº¹ê»ÚÁ{§ÉÀ³¥Î www.cghjournal.org/article/S1542-3565(24)00667-0/fulltext

...¦b MASH ¹ê¨Ò¤¤¡A¤þÓi»ÄÂà®ò酶 (ALT) §ïµ½ 17 U/L¡A»P¨ä¥L¬ã¨s¤¤ªº¨xŦ²Õ´¾Ç§ïµ½¦³Ãö¡C

¦pªG ALT ¨S¦³§ïµ½¡APDFF ´î¤Ö≥30% ¤´µM¥i¥H¹w´úÀø®Ä¡C

­Y¥X²{¥H¤U±¡ªp¡A«hÄ~ÄòªvÀø¡G

®ò°òÂಾ酶±o¨ì§ïµ½¡]»P°ò½u©Î¥¿±`¤Æ¬Û¤ñ¡^¡C

®ò°òÂಾ酶í©w¡A¦ý¦³¯e¯f§ïµ½ªº¨ä¥L¸ñ¶H¡]¨Ò¦p¡AMRI-PDFF ªº§ïµ½¡^¡C

------------------------------------------------------------------------------------

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/21 ¤W¤È 07:56:14²Ä4106½g¦^À³

¦å²M ALT ¤ô¥­¤ñ[¯Ø®q¯À§Ü©Ê]©Î[Åé­«]§ó¯à¹w´ú²Õ´¾ÇÅܤơA¨Ã¥B¥i¥H[§@¬°ªvÀøªº¦³®Ä«ü¼Ð]¡C

1.SNP-610­°§C29.5 U/L

2.µL¨x¬rSNP-810Á{§É¸ÕÅç¨S¦³¥ô¦ó¨ü¸ÕªÌªºALT¶W¹L¥¿±`­È¤W­­ªº3­¿¥H¤W¡AÅã¥Ü©Ò¦³¾¯¶q²Õ§¡¥¼¹F¨x¬r©Ê¼Ð·Ç¡C

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/24 ¤U¤È 01:19:08²Ä4123½g¦^À³
·|­û:ROGER588910148151µoªí®É¶¡:2025/5/24 ¤U¤È 12:39:59²Ä4120½g¦^À³

¦³½ìªº¬O¡A¬ã¨sÆ[¹î¨ìCYP2E1§í¨î¥i¥H [¥[³t]AILI(APAP»¤¾É©Ê¨x·l¶Ë)±ß´Áªº [¨xŦ«ì´_]¡C

¦ýµ²½×¥u¬Oªì¨Bªº¡A¨xŦ¦A¥Í¥Íª«¼Ð°OªºÅܤƤ´¦³«Ý¶i¤@¨B½T©w¡C

---------------------------------------------------------------------------------

±N HSC ¥­¿Å±qÅÖºû¤ÆÂà¦V¨xŦ«OÅ@¥i¯à¥Nªí¤@ºØ·s¿oªº¾ãÅéªvÀø¤èªk

CYP2E1§í¨î¥[³t¨xŦ«ì´_¡A±N¨x·l¶ËÂà¦V¨xŦ«OÅ@?(SNP-610»PSNP-630ÃĪ«?)

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/24 ¤U¤È 01:10:37²Ä4122½g¦^À³
[ÄAÂЦʦ~»{ª¾]¬ã¨sµû½×¤å:±N HSC ¥­¿Å±qÅÖºû¤ÆÂà¦V¨xŦ«OÅ@¥i¯à¥Nªí¤@ºØ·s¿oªº¾ãÅéªvÀø¤èªk

2025.5.22-¨x¬Pª¬²Ó­M(HSC)¡G°·±d©M¯e¯fª¬ºA¤UªºÅ餺¥­¿Å¡B«O¨x©MÅÖºû¤Æ

www.nature.com/articles/s41575-025-01068-6

ÀR¤îªºHSC³z¹L»P¤º¥Ö²Ó­M¡B®w´¶¥±²Ó­M©M¨x²Ó­Mªº³q°Tµo´§¨xŦíºA¤¤ªºÃöÁä¥\¯à¡C

¬¡¤Æªº HSC ¥Nªí¥D­nªºÅÖºû¤Æ²Ó­MÃþ«¬¡A«P¶i¨xÅÖºû¤Æ¡B¨xµw¤Æ¡Bªù¯ß°ªÀ£©M¨xÀùªºµo®i¡C

¥Ø«eªºªvÀø·§©À¨Ã¥¼¦Ò¼{¨ì HSC ¥­¿Å±qÅ餺¥­¿Å©M«O¨x¥\¯à¦VÅÖºû¤Æ¥\¯àªºÂàÅÜ¡A¥i¥H§Q¥Î³o¤@ÂàÅܦP®É§í¨îÅÖºû¤Æ¨Ã«ì´_¨xŦÅ餺¥­¿Å¡C

--------------------------------------------------------------------------------------

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/20 ¤U¤È 09:20:25²Ä4104½g¦^À³1½g

[ÄAÂЦʦ~»{ª¾]¬ã¨s--·|±a¨ÓÅå³ß¶Ü???

HSCs¥i³z¹LRSPO3©MWNT°T¸¹¬¡¤Æ¨Ó±±¨î¨xŦ[¤À°Ï]¡B[¥NÁÂ]¡B[·l¶Ë] ©M [¦A¥Í]

HSCs¤¤ [RSPO3] ªí²{»P¨x²Ó­M¤¤[WNT¼Ð¹v°ò¦]CYP1A2©M CYP2E1]ÅãµÛ¬ÛÃö!

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/24 ¤U¤È 12:47:29²Ä4121½g¦^À³
·|­û:ROGER588910148151µoªí®É¶¡:2025/5/24 ¤U¤È 12:39:59²Ä4120½g¦^À³

¦³½ìªº¬O¡A¬ã¨sÆ[¹î¨ìCYP2E1§í¨î¥i¥H [¥[³t]AILI(APAP»¤¾É©Ê¨x·l¶Ë)±ß´Áªº [¨xŦ«ì´_]¡C

§@¬°Á{§É¤W APAP ¹L¶qªº°ß¤@¸Ñ¬r¾¯¡ANAC ¤´¦³³\¦h¯ÊÂI¡A¨Ò¦pªø´ÁªvÀø«á¨xŦ«ì´_[©µ¿ð]

----------------------------------------------------------------------------------

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/20 ¤U¤È 09:20:25²Ä4104½g¦^À³

1½g[ÄAÂЦʦ~»{ª¾]¬ã¨s--·|±a¨ÓÅå³ß¶Ü???

HSCs¥i³z¹LRSPO3©MWNT°T¸¹¬¡¤Æ¨Ó±±¨î¨xŦ[¤À°Ï]¡B[¥NÁÂ]¡B[·l¶Ë] ©M [¦A¥Í]

HSCs¤¤ [RSPO3] ªí²{»P¨x²Ó­M¤¤[WNT¼Ð¹v°ò¦]CYP1A2©M CYP2E1]ÅãµÛ¬ÛÃö!

----------------------------------------------------------------------------------

CYP2E1§í¨î¥i¥H[¥[³t]APAP»¤¾É©Ê¨x·l¶Ë±ß´Áªº[¨xŦ«ì´_]

APAP¹L¶qªº°ß¤@¸Ñ¬r¾¯NACªø´ÁªvÀø«á¨xŦ«ì´_[©µ¿ð]

CYP2E1§í¨î¥i¥H[¥[³t]»P[ÄAÂЦʦ~»{ª¾]¬ã¨s¦³ÃöÁp¶Ü????

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/24 ¤U¤È 12:39:59²Ä4120½g¦^À³
2025.4.17-¥t1¤ä¹Î¶¤¬ã¨sÅçÃÒCYP2E1§í¨î-->¿E¬¡ PPAR£\

¦³½ìªº¬O¡A¬ã¨sÆ[¹î¨ìCYP2E1§í¨î¥i¥H [¥[³t]AILI(APAP»¤¾É©Ê¨x·l¶Ë)±ß´Áªº [¨xŦ«ì´_]¡C

¦³½ìªº¬O¡A¬ã¨sÆ[¹î¨ìCYP2E1§í¨î¥i¥H [¥[³t]AILI(APAP»¤¾É©Ê¨x·l¶Ë)±ß´Áªº [¨xŦ«ì´_]¡C

¦³½ìªº¬O¡A§Ú­ÌÆ[¹î¨ì si- Cyp2e1 LNPs ¥i¥H¥[³t AILI ±ß´Áªº¨xŦ«ì´_¡C¦ýµ²½×¥u¬Oªì¨Bªº¡A¨xŦ¦A¥Í¥Íª«¼Ð°OªºÅܤƤ´¦³«Ý¶i¤@¨B½T©w¡C

§@¬°Á{§É¤W APAP ¹L¶qªº°ß¤@¸Ñ¬r¾¯¡ANAC ¤´¦³³\¦h¯ÊÂI¡A¨Ò¦pªø´ÁªvÀø«á¨xŦ«ì´_©µ¿ð¡B¤£¨}­G¸z¹D¤ÏÀ³ ¡C¥»¬ã¨sªí©ú¡A³z¹LLNP»¼°eªº°w¹ïCyp2e1ªºsiRNA¥i¥H´î»´APAP¹L¶q¤Þ°_ªº«æ©Ê¨x·l¶Ë¡A¬°®¾±ÏAPAP¤¤¬r´£¨Ñ¤F¤@ºØ·sªºªvÀøµ¦²¤¡A©Ý¼e¤FRNAi¦b«æ©Ê¨x¯f¤¤ªºÀ³¥Î¡C

-------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/5/28 ¤U¤È 05:22:04²Ä 2031 ½g¦^À³

ªYÄ£¥²­nÅçÃÒ³o½g½×¤å´£¥Xªº¾÷¨î:SNP610(CYP2E1§í¨î-->¤º·½©Ê¥NÁª«ÅãµÛ¼W¥[-->¿E¬¡ PPAR£\-FGF21)

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/24 ¤W¤È 11:50:00²Ä4119½g¦^À³
·|­û:ROGER588910148151µoªí®É¶¡:2025/4/26 ¤U¤È 03:02:59²Ä4054½g¦^À³

¤Úµá¯S»¡¡G¡u¿ú·|±q¨S¦³­@¤ßªº¤H¤â¤¤¡AÂಾ¨ì¦³­@¤ßªº¤Hªº¤â¤¤¡C¡v¦¨¥\³ÌÃø¼õªº®É¨è¡A´N¬O¦¨¥\«eªº¨º¤@¨è¡C

¨È°¨»¹³Ð¿ì¤H¨©¦õ´µ´¿°Ý¤Úµá¯S¡G¡u§Aªº§ë¸ê¤èªk²³æ¡A¬°¤°»ò´X¥G¨S¤H¯à½Æ»s©O¡H¡v

¤Úµá¯S¦^µª¡G¡u¦]¬°¨S¦³¤HÄ@·NºCºCÅܱo´I¦³¡C¡v

--------------------------------------------------------------------------------------

¡u¦]¬°¨S¦³¤HÄ@·NºCºCÅܱo´I¦³¡C¡v---ºC´N¬O§Öªº¶ø¸q¡A­«ÂI¦b§ä[¹ïªº¤½¥q]ªø´Á§ë¸ê~

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/24 ¤W¤È 11:45:10²Ä4118½g¦^À³
·|­û:ROGER588910148151µoªí®É¶¡:2025/5/20 ¤W¤È 11:11:40²Ä4099½g¦^À³

[¿W®a±ÂÅv]©x¥q¨S§¹¨S¤F¡AÅý§Úµh¥¢µo¤j°]¾÷·|~

2025.5.19-AOP©x¥q®× ÃĵØÃÄ´£ºM¾P¥òµô Âù¤è¡uªk°|¨£¡v

----------------------------------------------------------------------------------------

±i¶vÚ¬»{ÁÊ256±i¡A»{Áʪ÷ÃB¬ù6,000¸U¤¸

¥Î¦o·í°Ñ¦Ò¡A«¥±i¼Æ¤ñ¦o¦h¡Aª÷ÃB¤ñ¦o¤Ö¡A¦]¬°¨º³õ©x¥q§Úµh¥¢µo¤j°]¾÷·|~

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/24 ¤W¤È 11:40:30²Ä4117½g¦^À³
­P´I¤§¹D¡A§Ö´N¬OºC¡AºC´N¬O§Ö!(¨ä¤¤¶ø¸q¥u¦³¸g¾ú¤~¯àÅé·|)

¤µ¤Ñ³o¤½¥q¦b¥²´Iºô¶R»ù180¤W¤U¡A½æ»ù220¤W¤U(¹w­p500¤¸¥H¤W¤H¨ú§Ú±ó)¡C

¶R¤J«á¦³1/2ªº®É¶¡¡AªÑ»ù´N¬O1±ø¾î½u¡Aªñ´X¦~¨ÓÀ禬Àò§Q¶}©lÃzµo~

¥Ø«e¤j·§¬O40­¿³ø¹S²v(¤wÃi±oºëºâ)¡A¹w­p100­¿³ø¹S²v«á¤H¨ú§Ú±ó¡C

-----------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/4/24 ¤U¤È 05:38:46²Ä 1919 ½g¦^À³

¤µ¤Ñ¤â¤W³o®a¥¼¤W¥«¤½¥q¦b¥²´Iºô¶R»ù128~129¡A½æ»ù150¡C(¹w­p250¤¸¥H¤W¤H¨ú§Ú±ó)

....9¦~«e«Ü¦h¤H¥ÎÁ«·l»ù½æ¥X¡A«Ü¦nij»ù¦b¤Q¶ôªì¦¨¥æ¡C

·|§ë¸ê³o®a¤½¥q¬Oª¾¹D¨ä²£«~ªùÂe·¥°ª(¥xÆW«ÜÃø¦A¦³²Ä2®a¥X²{)¡C

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/6/20 ¤W¤È 10:58:06²Ä 1226 ½g¦^À³

...¦pªG¤£¬O5¦~«e»P¤@¦ì¬ãµo¸g²z²á¤Ñ«á³B²zX«ùªÑ(¿ù»~ªº¨M©w)¡A²{¦b¤â¤WX±i¡C

---------------------------------------------------------------------------------------

·|­û:ROGER588910148151µoªí®É¶¡:2024/8/6 ¤W¤È 07:30:55²Ä3926½g¦^À³·|­û¡GROGER588910148151 µoªí®É¶¡:2024/7/9 ¤U¤È 05:06:23²Ä 3890 ½g¦^À³

¡§1¦~5­¿ªÌ¦p¹L¦¿¤§ÃV¡B5¦~1­¿ªÌ«o¹é­Y¨°¬P¡¨(®©¤£¥X? ¦^·Q¤@¤U°ê¹©¿ÄÂ_¤W300.....)

§Ú¬J¬ÝªÅ´N¤£°µ¦h¤]¤£°µªÅ¡A°O¤£²M¬O¨º¦~¼o¤F¿Ä¸ê¨é¸ê®æ¡C

­P´I¤§¹D¡A§Ö´N¬OºC¡AºC´N¬O§Ö¡AµLÄߪi°Ê¡A[°í«ù¦Û§Ú§PÂ_]

·|­û:dk10140377µoªí®É¶¡:2025/5/23 ¤U¤È 11:05:07²Ä4116½g¦^À³
¤µ±ß¬üªÑ©Ô¤F400ÂI°_¨Ó¡A¬Ý¬Ý会¤£会¦³¬¡¤ô来ªY药¡A¤@¯ë来说¤K¤Ó会¦bªÑ东会¤½§i±Â权¡C¥»ª©¤@开©l¬O2020¦~¡A³£­n5¦~¤F¡A¤H¥Í¦³¦h¤Ö个5¦~¡C
·|­û:dk10140377µoªí®É¶¡:2025/5/23 ¤W¤È 09:53:12²Ä4115½g¦^À³
¥x湾·s药诈骗¤§°ª¡A¥Á众¯}产ªÌ众¡A过¥b¤ñ¨Ò¬O误«H¤½¥q­J说¤K¹D¡A

²×©ó¦b¤µ¦~ªÑ东会¤ÞÃzÅå¤Ñ«ã¤õ???会¤£会¤]¥X¤@¤¿¶û???¦Ó¤Ï¦¨Ã¹»«º~???

¤½¥q过¤Ó²n´N¬O没¦³ªÑ东当场¬~脸¡A¤£过¤]´N¬O¨C¦~¬~¤@¦¸¡A¤S²n²n¦ÛªÎ¤@¦~¡C

学学³¢¸³呛ªÑ东¡A§â¤â¤Wªº¤@­¿¥[ɲ买¦^¡A¬Ò¤j欢³ß

=================

¬ü°êÂåÀø¶O¤§°ª¡A¥Á²³¥Ó½Ð¯}²£ªÌ¡A¹L¥b¤ñ¨Ò¬O¦]¬°ÂåÀø±b³æªº­ì¦]¡A²×©ó¦b¥h¦~¤ÞÃzÅå¤Ñ«ã¤õ¡A¤¿¶û¤Ï¦¨Ã¹»«º~!

2024.12.16-¬ü°êÂå®v­åªR­ì¦]¡GÂå«OÀsÀY CEO ¾Dºj±þ¡A¤¿¶û«o³Q·í¦¨¡u¥þ¥Á­^¶¯¡v¡H

crossing.cw.com.tw/article/19536

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/22 ¤U¤È 12:00:58²Ä4114½g¦^À³
¬ü°êÂåÀø¶O¤§°ª¡A¥Á²³¥Ó½Ð¯}²£ªÌ¡A¹L¥b¤ñ¨Ò¬O¦]¬°ÂåÀø±b³æªº­ì¦]¡A²×©ó¦b¥h¦~¤ÞÃzÅå¤Ñ«ã¤õ¡A¤¿¶û¤Ï¦¨Ã¹»«º~!

2024.12.16-¬ü°êÂå®v­åªR­ì¦]¡GÂå«OÀsÀY CEO ¾Dºj±þ¡A¤¿¶û«o³Q·í¦¨¡u¥þ¥Á­^¶¯¡v¡H

crossing.cw.com.tw/article/19536

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/22 ¤W¤È 08:48:50²Ä4113½g¦^À³
[³B¤èÃÄ]¹ï¤AñQ®ò°ò×ô¹L¶q³y¦¨ªº¨xŦ·l®`¬O¤@­Ó [ÄY­«ªº¤½¦@½Ã¥Í°ÝÃD]!

[«D³B¤èÃÄ]¹ï¤AñQ®ò°ò×ô¹L¶q¦Ó³y¦¨ªº¨xŦ·l®`¡A¤£¬O¤@­Ó[ÄY­«ªº¤½¦@½Ã¥Í°ÝÃD]?

§Ú¤£ª¾¹D¡u¤½¦@½Ã¥Íªº»ù­È¡v¦h¤Ö? $$$¥Ñ°ê»Ú¤jÃļt¥X¤â´¦¾å!!!

---------------------------------------------------------------------------------

2011¦~¹w§i±Ä¨ú±¹¬I:

¬ü°ê­¹«~ÃĪ«ºÞ²z§½(FDA¡^¥¿¦b±Ä¨ú±¹¬I­°§C[³B¤èÃÄ]²£«~¤¤¹ï¤AñQ®ò°ò×ôªº³Ì¤j¾¯¶q³æ¦ì±j«×¡C³o¶µÅܧó±N´£¨Ñ§ó¤jªº [¦w¥þÃä»Ú]¡A [¦³§U©ó¨¾¤î¦]¹ï¤AñQ®ò°ò×ô¹L¶q¦Ó³y¦¨ªº¨xŦ·l®`¡A³o¬O¤@­ÓÄY­«ªº¤½¦@½Ã¥Í°ÝÃD]¡C¸Ó³qª¾¸ÑÄÀ¤F­°§C¾¯¶q³æ¦ì±j«×ªº­ì¦]¡A¨Ã´y­z¤F FDA ¦p¦ó°w¹ï¶W¹L·sªº³Ì¤j¤ù¾¯©Î½¦Ån±j«×ªº¤w§å­ã³B¤èÃIJ£«~¹ê¬I¸Ó³qª¾¡C FDA ÁÙ­n¨D¹ï§t¦³¹ï¤AñQ®ò°ò×ôªº³B¤èÃIJ£«~ªº¦w¥þ¼ÐÅÒ¶i¦æ­×§ï¡A¥]¬A¼W¥[·sªº¶Â®ØÄµ§i¡A¥H±j½Õ¦³Ãö¨x·l¶Ë­·ÀIªº·s¦w¥þ¸ê°T¡C

----------------------------------------------------------------------------------------

2014¦~¤½§i-FDA ­n¨DÁ{§ÉÂå¥Í­­¨î¤AñQÓi×ôªº³B¤è

FDA «ØÄ³Á{§ÉÂå¥Í°±¤î¶}¥ß©M°tµo¨C¾¯§t¦³¶W¹L 325 ²@§J¹ï¤AñQ®ò°ò×ôªº½Æ¤èÃĪ«¡C

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/22 ¤W¤È 07:21:11²Ä4112½g¦^À³
·|­û:ROGER588910148151µoªí®É¶¡:2023/5/31 ¤U¤È 01:50:02²Ä3235½g¦^À³

2022.3.4--¬ü°ê¬rª«¤¤¤ßªº¨àµ£¦Û±þ¨Æ¥ó³ø§i

.¹ï¨Ó¦Û°ê®a¬rª«¼Æ¾Ú¨t²Îªº¼Æ¾Ú¶i¦æ¤F¤ÀªR¡A¥H¤F¸Ñ 2015 ¦~¦Ü 2020 ¦~¶¡©Ò¦³ºÃ¦ü¨àµ£¦Û±þ²v©MÀW²vªºÁͶաC¤ÀªR¤F 514,350 ¦W¨àµ£ºÃ¦ü¦Û±þ¨Æ¥ó¡A¨ä¤¤ 10 ¦Ü 12 ·³¨àµ£ªººÃ¦ü¦Û±þ²v¼W´T³Ì¤j (109.3%¡Ap  = 0.002)¡C13 ¦Ü 15 ·³ (30.3%, p  < 0.001) ©M 16 ¦Ü 19 ·³ (18.1%, p < 0.05)¡C³Ì±`¥Îªºª«½è¬O¥¬¬¥ªâ©M¹ï¤A酰®ò°ò×ô¡A¹ï¤A酰®ò°ò×ôªº±µÄ²²v¼W´T³Ì¤j.....

--------------------------------------------------------------------

OTC[«D³B¤è]ªºAPAPªº¦í°|²v¹ê»Ú¤W«D¦ý¨S¦³´î¤ÖÁÙ[¼W¥[][¼W¥[]---

FDA«ç»ò¸Ñ¨M¤W­±2­Ó¿S¤â°ÝÃD? ³Ì²³æ¦³®Ä¤è¦¡:³]ªkÅý«D³B¤è¶q¾P°â¶q¤U­°(³B¤èÃļƶq³Ñ1/3)¡A¦Ü©ó¾P°âÃB¤j´î¨º¬O¤jÃļtªº¨Æ!

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/22 ¤W¤È 07:01:35²Ä4111½g¦^À³
§Ú¥b±í¤ôªº¯à¹w¨£FDA±N¥X¤âÄY¥[ºÞ¨î«D³B¤èAPAP¡A°ê»Ú¤jÃļt­n¾ÇÀk³¾§âÀY®I¶i¨F¸Ì¬Ý¤£¨£©ÎªÌ¿ï¾Ü¶}µo§ó¦w¥þªº¤îµhÃĪv¥»?
·|­û:ROGER588910148151µoªí®É¶¡:2025/5/22 ¤W¤È 06:22:52²Ä4110½g¦^À³
µ²½×:1.FDAªº±j¨î¤âªk¥u¹ï[³B¤èÃÄ]¦³®Ä----³B¤è³æ¼Æ¶q³Ñ¤£¨ì¥H«eªº1/3¡A¤¤¬r¦í°|¤H¼ÆÁÙ¤£¯à´î¤Ö¡A¥i¯u¬O¨£°­¤F!

---------------------------------------------------------------------------------

OTC[«D³B¤è]ªºAPAPªº¦í°|²v¹ê»Ú¤W«D¦ý¨S¦³´î¤ÖÁÙ[¼W¥[][¼W¥[]---¼Æ¾Ú¤w¹G­¢FDA¹ï[«D³B¤è]APAPÄY¥[ºÞ¨î¡A ¤jÃļt¾P°âÃB·|¤£´î¤Ö¤]¬O¨£°­¤F!

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/22 ¤W¤È 06:10:04²Ä4109½g¦^À³
¥@¬É¯Å¤jÃļtªº¡u¤½¦@½Ã¥Íªº»ù­È¡v¬O¤°»ò?

¦@¦P§@ªÌ§Æ±æ FDA±À¥X·sªº¤½¦@½Ã¥Í¬Fµ¦(¦p¦P­^°ê)¨Ó­­¨î¤AñQÓi×ô¨x·l¶Ë

1.¯kµh¬O¥þ²y¤½¦@½Ã¥ÍªºÀu¥ý¨Æ¶µ

bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-11-770

...±N¯kµh²z¸Ñ¬°¤½¦@½Ã¥ÍÀu¥ý¨Æ¶µ¦³§U©ó¸ÑÄÀ¨ä»P°·±dªºªÀ·|©M¸gÀÙ¨M©w¦]¯Àªººò±KÁpô¡C

2.«D¦ÛµM­ì¦]¾É­P¤£¥­µ¥Åý§Ú­Ì¥Í¯f¶Ü¡Hwww.youtube.com/watch?v=aTIPBQMpF9Y

----------------------------------------------------------------------------------------

·|­û:ROGER588910148151µoªí®É¶¡:2024/6/7 ¤U¤È 06:10:56²Ä3778½g¦^À³

...¦¶³Í¥Á»¡¡A¥@¬É¯Å¤jÃļt³£¬O¥H¡u¤½¦@½Ã¥Íªº»ù­È¡v¬°³Ì¤j©v¦®¡A¦]¦¹¥¼¨Ó±N±Ä«D±MÄÝ¡B¤À°Ï±ÂÅvµ¦²¤¡A²{¶¥¬q±ÂÅvºN¦¡¤£³]­­±Ä¨ú¶}©ñºA«×¡ASNP-810¤]¤w¨ú±o¬ü°êOTC¡]«D³B¤èÃÄ¡^¥«³õ¾P°âÅv¡C

----------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/7 ¤U¤È 05:55:52²Ä 3776 ½g¦^À³

FDA¶}îÔ¤F!

±µ¤U¨Óªº¤T¦~¤º¸Ñ¨Mªº­p¹º±MµÛ¬¡°Ê(2020.3.27-¤t´¶Ã±¸p¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï­²ªk®×¡n

...FDA±N¥L­ÌÃö©ó±N­þ¨Ç¬¡°Ê¦C¤J¹w´úªº¨Mµ¦´y­z¬°³q±`¥H [¤½¦@½Ã¥Í] Àu¥ý¨Æ¶µ¬°«ü¾É¡v....

----------------------------------------------------------------------------------------

·|­û:ROGER588910148151µoªí®É¶¡:2024/6/6 ¤W¤È 07:00:59²Ä3770½g¦^À³

2023.3.20--¥²¶·°µ§ó¦hªº¤u§@¨Ó´î¤Ö¹ï¤AñQ®ò°ò×ôªº¨x¬r©Ê(«D³B¤èªº¦í°|²v«D¦ý¨S¦³´î¤ÖÁÙ¼W¥[ ¼W¥[ ¼W¥[)

...¡m¬ü°êÂå¾Ç·|Âø»x¡n(JAMA) ³Ìªñµoªí¤F¤@¶µ¬ã¨s¡A±´°Q¤F³o¶µ³W©w¹ï¤½¦@°·±dªº¼vÅT¡A¨Ã±o¥Xµ²½×.....

¦Û 2011 ¦~¥H¨Ó¡A¦]³æ¥Î¹ï¤AñQ®ò°ò×ô²£«~(«D³B¤èÃÄ)ªº¬r©Ê¦Ó¦í°|ªº¤H¼Æ³v¦~¼W¥[¡C

µ²½×:1.FDAªº±j¨î¤âªk¥u¹ï³B¤èÃĦ³®Ä¡AOTC[«D³B¤è]ªºAPAPªº¦í°|²v¹ê»Ú¤W«D¦ý¨S¦³´î¤ÖÁÙ[¼W¥[][¼W¥[]¡C

2.¦@¦P§@ªÌ§Æ±æ FDA±À¥X·sªº¤½¦@½Ã¥Í¬Fµ¦(¦p¦P­^°ê)¨Ó­­¨î¤AñQÓi×ô¨x·l¶Ë¡A¦ý¬Û«H³Ì¦nªºªø´Á¿ï¾Ü¬O¶}µo§ó¦w¥þªº¤îµhÃÄ¡C

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/21 ¤W¤È 09:32:36²Ä4108½g¦^À³
GSK¬ì¾ÇªøTony Woodªí¥Ü¡G¡uFGF21ÃþÃĪ«¦bMASH¤è­±¤wÅã¥Ü¥X¤@¨Ç¥O¤H®¶¾Äªº¸ê®Æ¡A¥]¬A [°fÂà¨xµw¤Æªº¯e¯f­º¦¸ÃÒ¾Ú]

....Efimosfermin±NÅãµÛÂX¥R§Ú­Ìªº¨x¯fÃĪ«¬ãµo²£«~½u¡A¨Ã¬°§Ú­Ì´£¨Ñ¶}µo¤@ºØ·sªº¼ç¦b¦PÃþ³Ì¨ÎÃĪ«ªº¾÷·|¡A¥i±æ©ó2029¦~­º¦¸±À¥X¡C¥¦»P¥¿¦b¶}µo¥Î©óªvÀøALD©MMASHªºGSK¡¦990¬Û»²¬Û¦¨¡A¬°GSK´£¨Ñ¤F¶}µo [³æÃĪvÀø] ©M¼ç¦b [¦@¦PªvÀø] ¥H§ïµ½¯f±wªvÀø®ÄªGªº¿ï¾Ü¡C¡v

------------------------------------------------------------------

FGF21°fÂà[¨xµw¤Æ]ªº¯e¯f­º¦¸ÃÒ¾Ú(GSK¯{20»õ¬ü¤¸ªº­ì¦])---²Å¦X§Ú2023¦~»¡F4(ªì´Á¨xµw¤Æ)¤~¬O³Ì¤jªºÂê÷®w!

·|­û:ROGER588910148151µoªí®É¶¡:2025/5/21 ¤W¤È 08:20:32²Ä4107½g¦^À³
¡m·s­^®æÄõÂå¾ÇÂø»x¡n©ó 2020 ¦~µoªíªº¤@¶µ¬ã¨sªí©ú¡AGLP-1 ¹ïÅÖºû¤Æ¨S¦³§ïµ½¡A¸Ó¬ã¨s¤¤¡A±w¦³ MASH ©M 2 ´Á©Î 3 ´ÁÅÖºû¤Æªº±wªÌ³QÀH¾÷¤À°t±µ¨ü¨C¤é¤@¦¸ªº¥q¬ü®æ¾|肽 (Ozempic¡BWegovy¡F¿Õ©M¿Õ¼w) 0.1 ²@§J¡B0.2 ²@§J©Î 0.4 ²@§J¦w¼¢¾¯©ÎªvÀø¡CÁöµM»P¦w¼¢¾¯²Õ¬Û¤ñ¡A¨Ï¥Î¥q¬ü®æ¾|肽ªvÀøªº±wªÌ¤¤¡A¦³§ó¤j¤ñ¨Òªº¤H¹F¨ì MASH ®ø°h¥BÅÖºû¤Æ¨S¦³´c¤Æ¡A¦ýªvÀø²Õ©M¦w¼¢¾¯²Õ¤§¶¡ªºÅÖºû¤Æ¶¥¬q§ïµ½¨S¦³®t²§¡C¦]¦¹¡A»Ý­n§ó¦h¼Æ¾Ú¨Ó¤F¸Ñ GLP-1 ¦b MASH ¤¤ªº¦n³B¡C

--------------------------------------------------------------------------------------

¿Õ©M¿Õ¼wªvÀø²Õ©M¦w¼¢¾¯²Õ¤§¶¡ªº [ÅÖºû¤Æ]¶¥¬q§ïµ½¨S¦³®t²§¡C

§Ú­n¦^À³¥»¸ÜÃD
·|­û:
§@ªÌ:
¬ÛÃöªÑ²¼¤½¥q¦WºÙ:ªYÄ£¥ÍÂå
¤º®e:
½Ð¥ýµn¤J­Y±z©|µL·|­û¨­¤À¡A½Ð¥ý¥Ó½Ð±b¸¹
°Q½×°Ï¬ÛÃö³W©w¡G
1.­Y±b¸¹¶¢¸m¹L¤[¨t²Î·|¦Û°Êµn¥X¡A«ØÄ³¦b¼g¦n¤å³¹¨Ã¥B©|¥¼µo°e¤§«e¥ý¦æ½Æ»s¡A¥H§Kµo°e¥¢±Ñ«á¾É­P¤º¤å®ø¥¢¡I
2.½Ð¤Å°Q½×ªÑ²¼¶R½æ©Î´£¤Î¦¨¥æ»ù¦ìµ¥¨Æ©y¡A¤Z¬O¯d¤U¬ÛÃö¥æ©ö°T®§¡A¥»ºô±N¦Û°Ê§R°£¡A¹HªÌ±NµLªkÄ~Äò°Ñ»P°Q½×¡I
3.ÄY¸T¯d¤UÁpµ¸¤è¦¡¡A½Ñ¦pLINE¡BFB¡BE-mail¡B¹q¸Ü..µ¥¡A©Î¥H¥ô¦ó©ú¥Ü¡B·t¥Üµ¥¤âªk¶i¦æÁpµ¸¡A¹HªÌ±NµLªkÄ~Äò°Ñ»P°Q½×¡I
4.¬°Á×§K®ö¶Oºô¸ô¸ê·½¡A½Ð¤Å±N¬Û¦P¤º®e³sÄòµo¦b¦h­Ó¤£¦P¥DÃD¤º¡A©ÎªÌ³sÄòµo°e¦h­Ó·s¥DÃD¡A­Y¦³¦¹Ãþ¬~ª©¤§¦æ¬°±NµLªkÄ~Äò°Ñ»P°Q½×¡I
5.ÄY¸T·N¹ÏÂǥΥ»ºô¥­¥x¤½µM´²¥¬¤å¦r©ó²³¡A¦Ó«üÂÖ¡B«V°d©Î¶Ç­z¨¬¥H·´·l¥L¤H¦WÅA¤§¨ÆªÌ¡A­Y¦]¦Ó¯A¤Îªk«ß°ÝÃD¡A·§»P¥»¤½¥qµLÃö¡A·q½Ð¿í¦u¡C

·q½Ð´L­«¥»ºô¤§¸gÀç²z©À¨Ã¿í¦uª©³W¡AÁÂÁ¡C

¼s§i¦X§@ ¥¼¤W¥«ÂdªÑ²¼¬d¸ß ¥¼¤W¥«ºô¯¸¾ÉÄý ¥¼¤W¥«ÂdªÑ²¼±MÃD ¿³ÂdªÑ²¼±MÃD ¥¼¤W¥«ªÑ²¼-¶°¹Î¤ÀÃþ ²§·~Âà§ë¸ê¥Í§Þ·~ ¤U³æ±Ð¾Ç
¥¼¤W¥«|¥¼¤W¥«ªÑ²¼|³Ì±M·~ªº  ¥xÆW¥¼¤W¥«ªÑ²¼  °]¸gºô¯¸-Copyright©2022¡£¥²´Iºô¡¤ §K¥I¶OªA°È±M½u:0800-035-178 ªA°È«H½c:postmaster@berich.com.tw
¥»ºô¯¸¬° ¥¼¤W¥«ÂdªÑ²¼¬d¸ß,¥¼¤W¥«ªÑ²¼§Y®É·s»D,¥¼¤W¥«¤½¥q¤½§i,¿³ÂdªÑ²¼¶R½æ,·Ç¤W¥«ªÑ²¼,¤¤ÅҪѬÛÃö¸ê°T¤À¨É¥æ¬yªÀ¸sºô¯¸,¸ê®Æ¶È¨Ñ°Ñ¦Ò,¨Ï¥ÎªÌ½Ð¦Û¦æ·r°u!
¥»ºô¯¸¤£¤¶¤J·|­û¶¡¤§¥¼¤W¥«ªÑ²¼¶R½æ,³æ¯Â´£¨Ñ¥¼¤W¥«ªÑ²¼¦æ±¡,«ùªÑÂàÅý,¥¼¤W¥«ªÑ²¼¹L¤á¿Ô¸ß¶È´£¨Ñ¥¼¤W¥«ªÑ²¼¥æ©ö¥­¥xµ¹·|­û¨Ï¥Î,¨Ì¥»¸ê®Æ¥æ©ö«á¬ÕÁ«¦Û­t!